Phase I study of paclitaxel (taxol) and pegylated liposomal doxorubicin (caelyx) administered every 2 weeks in patients with advanced solid tumors (Q33342846)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study of paclitaxel (taxol) and pegylated liposomal doxorubicin (caelyx) administered every 2 weeks in patients with advanced solid tumors |
scientific article |
Statements
1 reference
Phase I study of paclitaxel (taxol) and pegylated liposomal doxorubicin (caelyx) administered every 2 weeks in patients with advanced solid tumors (English)
1 reference
Mavroudis D
1 reference
Kouroussis Ch
1 reference
Kakolyris S
1 reference
Agelaki S
1 reference
Kalbakis K
1 reference
Androulakis N
1 reference
Souglakos J
1 reference
Samonis G
1 reference
Georgoulias V
1 reference
1 January 2002
1 reference
Identifiers
1 reference